A successful RH ISO immunization in pregnancy and perinatal outcome

Authors

  • Hepsibah Kirubamani Department of Obstetrics and Gynaecology, Saveetha Medical College and Hospital, Chennai, Tamil Nadu, India
  • Pavithra Baskaran Department of Obstetrics and Gynaecology, Saveetha Medical College and Hospital, Chennai, Tamil Nadu, India
  • Nasreen Banu M. Department of Obstetrics and Gynaecology, Saveetha Medical College and Hospital, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.26452/ijrps.v13i2.342

Abstract

RH ISO immunization is a major cause of severe hemolytic Anemia in newborns and poor perinatal outcomes. Nowadays, the rate of isoimmunization is rising so careful monitoring and follow up is required in the mother to improve the perinatal mortality. A case of multigravida, Rh iso immunized with titre value of 1:8 ago; this case defines how the perinatal outcome with this level of titre value and the events of a baby after immediate delivery. Rh isoimmunization is diagnosed with Doppler ultrasound to calculate the MOM VALUE, if >1.5, then it needs an immediate termination, exchange transfusion, IVIG and double light phototherapy are the options in the treatment in Fetal Anemia. Advantages of IVIG use before transfusion case reports show a reduction in the transfusion rate and phototherapy. This case report showed the successful RH isoimmunization in pregnancy with an ICT titre of 1:8 and the related perinatal outcome. PSV AND MSV Doppler which is a noninvasive test which is used to benefit the Rh isoimmunization patient; however, if the mom is within normal limits, we can be able to prolong the pregnancy, or we might know when the ideal time is to terminate the pregnancy along with Doppler nowadays if titre of more than 1:32, IVIG is also one good option to eliminate the repeated exchange transfusions and phototherapy for the baby.

Keywords:

Immunization, ISO, Perinatal, Pregnancy, RH

Downloads

Download data is not yet available.

References

J R Kenneth J Moise. Management of rhesus alloimmunization in pregnancy. Obstetrics and Gynecology, 100(3):600–611, 2002.

S Valsami, M Politou, T Boutsikou, D Briana, M Papatesta, and A Malamitsi-Puchner. Importance of Direct Antiglobulin Test (DAT) in cord blood causes of DAT (+) in a cohort study. Pediatrics and Neonatology, 56(4):256–260, 2015.

M J Maisels. Managing the jaundiced newborn: a persistent challenge. CMAJ, 187(5):335–343, 2015.

Dick Oepkes. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med, 355(2):156–164, 2006.

A W Liley. Intrauterine transfusion of foetus in hemolytic disease. Br Med J, 2(5365):1107– 1109, 1963.

N A Murray and I A Roberts. Haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed, 92(2):83–88, 2007.

Published

2022-04-30

How to Cite

Hepsibah Kirubamani, Pavithra Baskaran, & Nasreen Banu M. (2022). A successful RH ISO immunization in pregnancy and perinatal outcome. International Journal of Research in Pharmaceutical Sciences, 13(2), 218–221. https://doi.org/10.26452/ijrps.v13i2.342